Neurology:新诊断房颤与晨起卒中和TIA独立相关

2013-04-24 高晓方 译 医学论坛网

  智利一项研究表明,新诊断房颤与晨起缺血性卒中和短暂性脑缺血发作(TIA)具有显著独立相关性,与无晨起事件患者相比,已发生晨起脑血管事件患者的新诊断房颤检测几率高3倍。论文4月17在线发表于《神经病学》(Neurology)。   研究者前瞻性评估2008至2011年间收治的所有急性缺血性卒中和TIA患者。对重要协变量进行校正之后,利用逐步多重Logistic回归分析评估新诊断房颤与晨起缺血性

  智利一项研究表明,新诊断房颤与晨起缺血性卒中和短暂性脑缺血发作(TIA)具有显著独立相关性,与无晨起事件患者相比,已发生晨起脑血管事件患者的新诊断房颤检测几率高3倍。论文4月17在线发表于《神经病学》(Neurology)。

  研究者前瞻性评估2008至2011年间收治的所有急性缺血性卒中和TIA患者。对重要协变量进行校正之后,利用逐步多重Logistic回归分析评估新诊断房颤与晨起缺血性卒中或TIA的相关性。

  结果显示,研究人群由356例患者组成,伴有急性缺血性卒中和TIA诊断者分别为274(77.0%)和82(23.0%)例。上述事件中有11.5%(41例)在晚间睡眠时发生。在272例无已知房颤患者中有27例被检出新诊断房颤(9.9%)。新诊断房颤与晨起缺血性卒中和TIA之间具有独立相关性(比值比3.6;P=0.019)。

卒中相关的拓展阅读:


Newly diagnosed atrial fibrillation linked to wake-up stroke and TIA
Background
Based on the higher frequency of paroxysmal atrial fibrillation during night and early morning hours, we sought to analyze the association between newly diagnosed atrial fibrillation and wake-up ischemic cerebrovascular events.
Methods
We prospectively assessed every acute ischemic stroke and TIA patient admitted to our hospital between 2008 and 2011. We used a forward step-by-step multiple logistic regression analysis to assess the relationship between newly diagnosed atrial fibrillation and wake-up ischemic stroke or TIA, after adjusting for significant covariates.
Results
The study population comprised 356 patients, 274 (77.0%) with a diagnosis of acute ischemic stroke and 82 (23.0%) with TIA. A total of 41 (11.5%) of these events occurred during night sleep. A newly diagnosed atrial fibrillation was detected in 27 patients of 272 without known atrial fibrillation (9.9%). We found an independent association between newly diagnosed atrial fibrillation and wake-up ischemic stroke and TIA (odds ratio 3.6, 95% confidence interval 1.2–7.7, p = 0.019).
Conclusions
The odds of detecting a newly diagnosed atrial fibrillation were 3-fold higher among wake-up cerebrovascular events than among non–wake-up events. The significance of this independent association between newly diagnosed atrial fibrillation and wake-up ischemic stroke and TIA and the role of other comorbidities should be investigated in future studies.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2019036, encodeId=a86a20190362c, content=<a href='/topic/show?id=0f5859913ad' target=_blank style='color:#2F92EE;'>#晨起卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59913, encryptionId=0f5859913ad, topicName=晨起卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Mon Jul 01 16:22:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915245, encodeId=dd72191524531, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Mar 06 03:22:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999283, encodeId=897c19992834c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jul 29 23:22:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2019036, encodeId=a86a20190362c, content=<a href='/topic/show?id=0f5859913ad' target=_blank style='color:#2F92EE;'>#晨起卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59913, encryptionId=0f5859913ad, topicName=晨起卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Mon Jul 01 16:22:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915245, encodeId=dd72191524531, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Mar 06 03:22:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999283, encodeId=897c19992834c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jul 29 23:22:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2014-03-06 rgjl
  3. [GetPortalCommentsPageByObjectIdResponse(id=2019036, encodeId=a86a20190362c, content=<a href='/topic/show?id=0f5859913ad' target=_blank style='color:#2F92EE;'>#晨起卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59913, encryptionId=0f5859913ad, topicName=晨起卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Mon Jul 01 16:22:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915245, encodeId=dd72191524531, content=<a href='/topic/show?id=e381586e94d' target=_blank style='color:#2F92EE;'>#新诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58679, encryptionId=e381586e94d, topicName=新诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Thu Mar 06 03:22:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999283, encodeId=897c19992834c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jul 29 23:22:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2013-07-29 yinhl1978

相关资讯

Circulation:基因多态性决定达比加群血药浓度及出血风险

RE-LY试验(Randomized Evaluation of Long-term Anticoagulation Therapy)结果显示达比加群酯110mg及150mg(每日两次)在预防非瓣膜性房颤患者卒中上优于华法林。两种剂型达比加群酯的大出血和轻微出血风险均较低。与维生素K拮抗剂不同,达比加群酯为固定剂量且不需抗凝监测。但达比加群活性代谢物血药浓度在不同个体之间存在较大的差异。遗传变异是

Ann Intern Med:房颤增痴呆风险再添新证

  伊朗学者的一项荟萃分析表明,在伴或不伴卒中病史的人群中,房颤均与认知缺损和痴呆风险升高相关。论文于2013年3月5日在线发表于《内科学年鉴》(Ann Intern Med)。   研究者检索了Medline、PsycINFO、Cochrane和EMBASE等数据库及相关参考文献,并确认了报告房颤与认知缺损相关性校正风险估计的前瞻性和非前瞻性研究。   结果显示,共有21

ACC 2013:房颤患者首次应用地高辛死亡率升高

  美国心脏病学会第62届科学年会(ACC2013)上的一项报告表明,与未应用地高辛的房颤患者相比,首次启用地高辛者的死亡率出现独立性显著升高,并且在各亚组人群中均为如此。   地高辛为目前尚在应用的最古老药物之一,并且从未就房颤治疗的有效性或安全性实施过实质性临床试验。此项研究共纳入23,272例既往未应用过地高辛的新诊断房颤患者,其中12.9%因心率控制而启动地高辛治疗。对年龄、种族、

FDA批准阿哌沙班预防非瓣膜性房颤患者卒中和栓塞

  12月28日,美国食品与药物管理局(FDA)批准了口服抗凝药阿哌沙班(商品名Eliquis,通用名apixaban)上市,用于减少非瓣膜性房颤患者的卒中和全身栓塞发生风险。      一项纳入18000余名患者的临床试验对比了阿哌沙班和华法林的安全性和有效性。结果显示,服用阿哌沙班的患者比服用华法林的患者卒中发生更少。   安装人工心脏瓣膜的患者和瓣膜性心房颤动患者不应

JACC:房颤伴心衰患者的生活质量和运动能力

房颤和心衰是心血管领域最常见的两种疾病,随着发病率的逐年增加,21世纪我们面临的两种最主要的疾病就是房颤和心衰,房颤和心衰往往在同一个患者中出现。AF-CHF研究共入选来自123个中心的1376例房颤伴心衰患者,比较节律控制和心率控制对患者预后的影响,结果提示通过37个月的随访,两组主要终点事件心血管死亡率无明显差异,次要终点事件全因死亡率、心衰恶化、脑卒中均无明显差异。 现有的研究认为节律控制

Nat Rev Cardiol:瑜伽有助于改善房颤患者的房颤负荷

2013年3月19日,《美国心脏病学会杂志》发表了一项小型单中心概念验证(proof-of-concept)研究——Yoga MyHeart的研究结果,该研究评估了瑜伽对49名有症状的阵发性房颤患者房颤负荷的影响。研究人员表示他们的结果“首次证明了瑜伽作为房颤的辅助疗法,可有效减轻房颤负荷和症状”。研究前3个月为对照期,随后3个月为试验期。试验期间患者每周至少参加两次艾杨格瑜伽课程,并鼓励他们课后